Molecules Engineered Against Oncogenic Proteins and Cancer: A Comprehensive Review

By E. J. Corey, a renowned chemist, this book provides an in-depth review of the latest molecular advances in cancer treatment. It documents the recent scientific breakthroughs that have revolutionized the field of oncology, offering new hope for cancer patients worldwide.

Small Molecule Kinase/KRAS Inhibitors: A New Frontier in Cancer Treatment

The book features 91 total small molecule kinase/KRAS inhibitors, with 80 of these inhibitors being FDA-approved. These inhibitors have been engineered to specifically block oncogene-induced carcinogenic proteins, leading to significant advancements in cancer treatment.

Structural Formulas of Kinase/KRAS Inhibitors in Clinical Trials

More than 100 kinase/KRAS inhibitors currently in clinical trials are presented in the book, providing valuable insights into their structural formulas and potential therapeutic applications.

Understanding Oncoprotein Inhibitors and Their Role in Cancer Treatment

Mutated protein kinases act as oncoproteins, driving the growth and proliferation of cancer cells. The book delves into the discovery process of these inhibitors, their mechanism of action, and their impact on advancing our understanding and treatment of cancer.

A Brief History of Oncoprotein Inhibitors and Their Impact on Cancer Research

The book offers a historical perspective on the development of oncoprotein inhibitors, highlighting their role in transforming the landscape of cancer research and treatment.

The Future of Cancer Treatment: Challenges and Opportunities

The discovery process of oncoprotein inhibitors is discussed in detail, including effective strategies for innovation, ongoing challenges, and a glimpse into the future of this rapidly evolving field.

Molecules Engineered Against Oncogenic Proteins and Cancer is an indispensable resource for researchers, students, and professionals in bioscience, medicine, chemistry, and oncology, as well as those involved in therapeutic discovery at industrial companies. It provides a comprehensive overview of the latest advances in cancer treatment, making it a must-read for anyone interested in this critical area of research.